Skip to main content
Log in

Midazolam + droperidol cost saving for acute agitation

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2015/2016 Australian dollars

Reference

  • Yap CYL, et al. Economic Evaluation of Midazolam-Droperidol Combination, Versus Droperidol or Olanzapine for the Management of Acute Agitation in the Emergency Department: A Within-Trial Analysis. PharmacoEconomics-Open : 24 Jul 2017. Available from: URL: http://dx.doi.org/10.1007/s41669-017-0047-y

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Midazolam + droperidol cost saving for acute agitation. PharmacoEcon Outcomes News 783, 24 (2017). https://doi.org/10.1007/s40274-017-4195-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-4195-1

Navigation